A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia

Belfort, Michael A.; Anthony, John; Saade, George R.; Allen, John C.
January 2003
New England Journal of Medicine;1/23/2003, Vol. 348 Issue 4, p304
Academic Journal
Objective Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia. Nimodipine is a calcium-channel blocker with specific cerebral vasodilator activity. Our objective was to determine whether nimodipine is more effective than magnesium sulfate for seizure prophylaxis in women with severe preeclampsia. Methods: We conducted an unblinded, multicenter trial in which 1650 women with severe preeclampsia were randomly assigned to receive either nimodipine (60 mg orally every 4 hours) or intravenous magnesium sulfate (given according to the institutional protocol) from enrollment until 24 hours post partum. High blood pressure was controlled with intravenous hydralazine as needed. The primary outcome measure was the development of eclampsia, as defined by a witnessed tonic–clonic seizure. Results: Demographic and clinical characteristics were similar in the two groups. The women who received nimodipine were more likely to have a seizure than those who received magnesium sulfate (21 of 819 [2.6 percent] vs. 7 of 831 [0.8 percent], P=0.01). The adjusted risk ratio for eclampsia associated with nimodipine, as compared with magnesium sulfate, was 3.2 (95 percent confidence interval, 1.1 to 9.1). The antepartum seizure rates did not differ significantly between groups, but the nimodipine group had a higher rate of postpartum seizures (9 of 819 [1.1 percent] vs. 0 of 831, P=0.01). There were no significant differences in neonatal outcome between the two groups. More women in the magnesium sulfate group than in the nimodipine group needed hydralazine to control blood pressure (54.3 percent vs. 45.7 percent, P<0.001). Conclusions: Magnesium sulfate is more effective than nimodipine for prophylaxis against seizures in women with severe preeclampsia. N Engl J Med 2003;348:304-11.


Related Articles

  • Magnesium Sulfate for Preeclampsia. Greene, Michael F. // New England Journal of Medicine;1/23/2003, Vol. 348 Issue 4, p275 

    Discusses the historical knowledge about and treatment of preeclampsia in pregnant women. Summary of treatment techniques in the 18th and 19th centuries; Discovery that eclampsia is associated with albuminuria in 1839 and hypertension in 1897; Maternal mortality due to eclampsia in the U.S....

  • Hypertensive Disorders of Pregnancy. Leeman, Lawrence; Fontaine, Patricia // American Family Physician;7/1/2008, Vol. 78 Issue 1, p93 

    The National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy has defined four categories of hypertension in pregnancy: chronic hypertension, gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension. A maternal blood...

  • Magnesium sulfate needs adding to essential drugs list, say experts.  // PharmacoEconomics & Outcomes News;3/8/2008, Issue 548, p2 

    The article discusses research being done on the use of magnesium sulfate for the treatment of eclampsia and severe preeclampsia. It references a study by Anna Langer et al, published in the March 2008 issue of "The Lancet." According to the author, the drug will significantly advance the safe...

  • Preeklampsinin Siddetini �ng�rmede Trombosit Vol�m �l��mlerinin Degerlendirilmesi ve �nemi. Dogru, Hatice Yilmaz; Y�cel, Nese; Pelit, Fatma �etin; Bolat, G�her // Perinatal Journal / Perinatoloji Dergisi;Dec2011, Vol. 19 Issue 3, p108 

    Objective: The aim of this study was to determine the correlation between trombocytes volume and severity of the disease on pregnants who diagnosed mild, severe preeclampsia or eclampsia. Methods: In this study 58 pregnants whose ages between 17 and 41 and past 28th week of delivery were...

  • Comparing MgSO4 to nimodipine for preeclamptic seizures.  // Contemporary OB/GYN;Apr2003, Vol. 48 Issue 4, p19 

    Focuses on a study that compared the effectiveness of intravenous magnesium sulfate and oral nimodipine in preventing seizures in women with sever preeclampsia. Suggested cause of eclampsia; Number of participants in the study; Independent factors for eclampsia in women with severe...

  • Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. Cnossen, Jeltsje S.; van der Post, Joris A. M.; Mol, Ben W. J.; Khan, Khalid S.; Meads, Catherine A.; Riet, Gerben ter // BMC Pregnancy & Childbirth;2006, Vol. 6, p29 

    Background: Pre-eclampsia, a syndrome of hypertension and proteinuria, is a major cause of maternal and perinatal morbidity and mortality. Accurate prediction of pre-eclampsia is important, since high risk women could benefit from intensive monitoring and preventive treatment. However, decision...

  • Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. Yu, Christina K. H.; Casas, Juan P.; Savvidou, Makrina D.; Sahemey, Manpreet K.; Nicolaides, Kypros H.; Hingorani, Aroon D. // BMC Pregnancy & Childbirth;2006, Vol. 6, p7 

    Background: Pre-eclampsia is thought to have an important genetic component. Recently, preeclampsia has been associated in some studies with carriage of a common eNOS gene Glu298Asp polymorphism, a variant that leads to the replacement of glutamic acid by aspartic acid at codon 298. Method:...

  • Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants. del Moral, T.; Gonzalez-Quintero, V. H.; Claure, N.; Vanbuskirk, S.; Bancalari, E. // Journal of Perinatology;Mar2007, Vol. 27 Issue 3, p154 

    Objective:Magnesium sulfate (MgSO4) is the most commonly used tocolytic agent in the US and is also employed as a prophylactic agent against seizures in pre-eclamptic women. MgSO4 crosses the placenta and its concentration in the newborn usually exceeds that of maternal levels. The purpose of...

  • Pre-eclampsia management in practice. Pryke, Rachel // Pulse;4/22/2002, Vol. 62 Issue 16, p60 

    Provides tips for general practitioners on pre-eclampsia management. Common conditions associated with pre-eclampsia; Management of patients having the condition; Suggested books and papers on pre-eclampsia and eclampsia.


Read the Article


Sign out of this library

Other Topics